|

Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

RECRUITINGN/ASponsored by University of Zurich
Actively Recruiting
PhaseN/A
SponsorUniversity of Zurich
Started2023-02-20
Est. completion2027-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06360627

Summary

Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* CT SCAN for pulmonary nodule detection/follow up
* CT SCAN for pneumonia detection/follow up

Exclusion Criteria:

* under 18
* BMI over 30

Conditions5

CancerLung CancerLung EmbolismPneumoniaRadiation Exposure

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.